Intranasal administration of E-selectin to induce immunological tolerization can suppress subarachnoid hemorrhage-induced vasospasm implicating immune and inflammatory mechanisms in its genesis

Brain Research

Volumn 1132, Issue 1, 2007, Pages 177-184

  Nakayama, Toshiyuki ^a,b   Illoh, Kachikwu ^c   Ruetzler, Christl ^a   Auh, Sungyoung ^a   Sokoloff, Louis ^b   Hallenbeck, John ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Basilar artery; E selectin; Immunomodulation; Mucosal tolerance; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY SPASM; ARTICLE; BASILAR ARTERY; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; SUBARACHNOID HEMORRHAGE; VASCULAR ENDOTHELIUM; VASOSPASM;

ADMINISTRATION, INTRANASAL; ANIMALS; BASILAR ARTERY; CELL ADHESION; E-SELECTIN; ENCEPHALITIS; ENDOTHELIAL CELLS; HYPERSENSITIVITY, DELAYED; IMMUNE TOLERANCE; IMMUNOSUPPRESSION; MALE; RATS; RATS, INBRED SHR; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME; VASOSPASM, INTRACRANIAL;

RATTUS;

EID: 33846195508     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.09.116     Document Type: Article

References (31)

1. Aladag M.A., Turkoz Y., Sahna E., Parlakpinar H., and Gul M. The attenuation of vasospasm by using a sod mimetic after experimental subarachnoidal haemorrhage in rats. Acta Neurochir. (Wien) 145 (2003) 673-677
2. Bates P.W., and Miyamoto S. Expanded nuclear roles for IkappaBs. Sci. STKE 2004 (2004) pe48
3. Ceviker N., Baykaner M.K., Keskil I.S., Sencer H., Ataoglu O., Ozsoy M., and Ercan Z.S. Immediate ultrastructural effects of endothelin-1 on rabbit basilar artery. A comparison between immersion and perfusion fixation techniques. Acta Neurochir. (Wien) 132 (1995) 104-109
4. Chen Y., Kuchroo V.K., Inobe J., Hafler D.A., and Weiner H.L. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265 (1994) 1237-1240
5. Chen Y., Ruetzler C., Pandipati S., Spatz M., McCarron R.M., Becker K., and Hallenbeck J.M. Mucosal tolerance to E-selectin provides cell-mediated protection against ischemic brain injury. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 15107-15112
6. Cher D.J., and Mosmann T.R. Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones. J. Immunol. 138 (1987) 3688-3694
7. Ducruet A.P., Vogt A., Wipf P., and Lazo J.S. Dual specificity protein phosphatases: therapeutic targets for cancer and Alzheimer's disease. Annu. Rev. Pharmacol. Toxicol. 45 (2005) 725-750
8. Dumont A.S., Dumont R.J., Chow M.M., Lin C.L., Calisaneller T., Ley K.F., Kassell N.F., and Lee K.S. Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery 53 (2003) 123-133 (discussion 133-5)
9. Faria A.M., and Weiner H.L. Oral tolerance: mechanisms and therapeutic applications. Adv. Immunol. 73 (1999) 153-264
10. Faria A.M., and Weiner H.L. Oral tolerance. Immunol. Rev. 206 (2005) 232-259
11. Fassbender K., Hodapp B., Rossol S., Bertsch T., Schmeck J., Schutt S., Fritzinger M., Horn P., Vajkoczy P., Wendel-Wellner M., Ragoschke A., Kuehl S., Brunner J., Schurer L., Schmiedeck P., and Hennerici M. Endothelin-1 in subarachnoid hemorrhage: an acute-phase reactant produced by cerebrospinal fluid leukocytes. Stroke 31 (2000) 2971-2975
12. Groux H., O'Garra A., Bigler M., Rouleau M., Antonenko S., de Vries J.E., and Roncarolo M.G. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389 (1997) 737-742
13. Hirashima Y., Nakamura S., Endo S., Kuwayama N., Naruse Y., and Takaku A. Elevation of platelet activating factor, inflammatory cytokines, and coagulation factors in the internal jugular vein of patients with subarachnoid hemorrhage. Neurochem. Res. 22 (1997) 1249-1255
14. Ho H., and Batjer H. Aneurysmal subarachnoid hemorrhage: pathophysiology and sequelae. In: Batjer H. (Ed). Cerebrovascular Disease (1997), Lippincott-Raven Publishers, Philadelphia 889-899
15. Joyce D.A., Gibbons D.P., Green P., Steer J.H., Feldmann M., and Brennan F.M. Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes. Eur. J. Immunol. 24 (1994) 2699-2705
16. Kassell N.F., Sasaki T., Colohan A.R., and Nazar G. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 16 (1985) 562-572
17. Kasuya H., and Shimizu T. Activated complement components C3a and C4a in cerebrospinal fluid and plasma following subarachnoid hemorrhage. J. Neurosurg. 71 (1989) 741-746
18. Kuwata H., Watanabe Y., Miyoshi H., Yamamoto M., Kaisho T., Takeda K., and Akira S. IL-10-inducible Bcl-3 negatively regulates LPS-induced TNF-alpha production in macrophages. Blood 102 (2003) 4123-4129
19. Lang R. Tuning of macrophage responses by Stat3-inducing cytokines: molecular mechanisms and consequences in infection. Immunobiology 210 (2005) 63-76
20. MacDonald R., and Weir B. Perioperative management of subarachnoid hemorrhage. In: Winn H. (Ed). Youmans Neurological Surgery (2004), Saunders, Philadelphia 1813-1838
21. Macdonald R.L., Zhang Z.D., Takahashi M., Nikitina E., Young J., Xie A., and Larkin L. Calcium sensitivity of vasospastic basilar artery after experimental subarachnoid hemorrhage. Am. J. Physiol.: Heart Circ. Physiol. 290 (2006) H2329-H2336
22. Mallat Z., and Tedgui A. The role of transforming growth factor beta in atherosclerosis: novel insights and future perspectives. Curr. Opin. Lipidol. 13 (2002) 523-529
23. Mayberg M.R., Batjer H.H., Dacey R., Diringer M., Haley E.C., Heros R.C., Sternau L.L., Torner J., Adams Jr. H.P., Feinberg W., et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 25 (1994) 2315-2328
24. McCartney-Francis N., Jin W., and Wahl S.M. Aberrant Toll receptor expression and endotoxin hypersensitivity in mice lacking a functional TGF-beta 1 signaling pathway. J. Immunol. 172 (2004) 3814-3821
25. Megyesi J.F., Vollrath B., Cook D.A., and Findlay J.M. In vivo animal models of cerebral vasospasm: a review. Neurosurgery 46 (2000) 448-460 (discussion 460-1)
26. Metzler B., and Wraith D.C. Mucosal tolerance in a murine model of experimental autoimmune encephalomyelitis. Ann. N. Y. Acad. Sci. 778 (1996) 228-242
27. Polin R.S., Bavbek M., Shaffrey M.E., Billups K., Bogaev C.A., Kassell N.F., and Lee K.S. Detection of soluble E-selectin, ICAM-1, VCAM-1, and L-selectin in the cerebrospinal fluid of patients after subarachnoid hemorrhage. J. Neurosurg. 89 (1998) 559-567
28. Ronkainen A., Miettinen H., Karkola K., Papinaho S., Vanninen R., Puranen M., and Hernesniemi J. Risk of harboring an unruptured intracranial aneurysm. Stroke 29 (1998) 359-362
29. Takeda H., Spatz M., Ruetzler C., McCarron R., Becker K., and Hallenbeck J. Induction of mucosal tolerance to E-selectin prevents ischemic and hemorrhagic stroke in spontaneously hypertensive genetically stroke-prone rats. Stroke 33 (2002) 2156-2163
30. Weiner H.L. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol. Today 18 (1997) 335-343
31. Williams L., Bradley L., Smith A., and Foxwell B. Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages. J. Immunol. 172 (2004) 567-576